Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in Non-Constipating Irritable Bowel Syndrome
2007-001950-18Phase 2Completed
- Sponsor
- Ocera Therapeutics
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing AST-120 with Placebo (2 arms). Primary endpoint: Reduction in days with abdominal pain. Started May 2007; status: completed.
02
Drugs
activated charcoal
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2007-001950-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001950-18.